Rating History for Ambrx Biopharma (AMAM) by Citizens

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/10/2024 Reni Benjamin Downgrade Market Perform
(Market Outperform)
N/A
(N/A)
27.47
(28.00)
1.93% Details